By shining red light on the skin over a mouse's heart, researchers at Washington University in St. Louis have figured out how to trigger an irregular heartbeat on demand—and watch, in real time, what happens to oxygen levels in the brain. The discovery, led by biomedical engineering professor Chao Zhou and graduate student Abby Matt, offers a new window into one of medicine's most dangerous rhythms: the kind of arrhythmia that can steal oxygen from the brain and set the stage for stroke or cognitive decline.
The work matters because the connection between heart rhythm and brain health has always been difficult to study safely. An irregular heartbeat means the heart pumps blood inefficiently, leaving organs starved of oxygen. When the brain is the victim, the stakes are high. Yet traditional methods for pacing a heart are invasive—they require implanting LED sources directly on the organ or using electrical leads that risk burning tissue. Researchers have needed a better tool.
Enter cardiac optogenetics: the marriage of genetic engineering and light. Zhou's team used genetically modified mice and shined red light through the skin to activate light-sensitive proteins in heart cells, allowing them to dial the heart rate up or down with precision. In their experiments, they ranged the pacing frequency from 6 Hz—slower than resting rate—to 14 Hz, well above it. The largest changes in the brain occurred at both extremes. Across all frequencies tested, the changes in blood and oxygen concentration were directly proportional to how far the pacing deviated from the resting heart rate.
What they found was striking: arrhythmia didn't just affect the heart. Working with radiology associate professor Adam Bauer, the team used highly sensitive imaging to track oxygen in the brain during and after each arrhythmia episode. They documented decreases in oxygenated hemoglobin and increases in deoxygenated hemoglobin—evidence that the brain's oxygen supply was being disrupted on a remarkably short timescale, moment by moment.
"We can use that to study highly perfused organs and how these are disrupted on a very short timescale," Matt explained. The advantage of their approach is elegance itself. Unlike implanted devices, optogenetics is noninvasive. The light-sensitive proteins only respond where they're expressed—in this case, the heart—giving researchers precise control without collateral damage or the need for wires and leads.
The team built on decades of innovation. Optogenetics itself began at Stanford University in 2005, primarily in neuroscience. Zhou first brought the technique to cardiac research in 2015, while at Lehigh University, demonstrating it in fruit flies. That work, also published in Science Advances, paved the way for increasingly sophisticated models responsive to different colors of light. The current study, appearing in the same journal, now extends the method to mammals, where the stakes—and the insights—are closer to human disease.
The researchers say the work is a proof of concept. Future studies may combine their optical imaging with other blood flow and oxygen saturation measurements to build a fuller picture of how arrhythmia ripples through the body. While today's experiments are limited to mice, the team believes the method could be extended to other cardiac optogenetic models with potential for translational medicine—research that eventually leads to human application.